APRE Wutah pendapatan triwulanan Aprea Therapeutics, Inc.

Simbol lan logo merek aprea.com (APRE)

The quarterly revenue growth of Aprea Therapeutics (APRE), as reflected in GURU.Markets quotes, is speculative due to the absence of sales during early clinical stages. Meanwhile, -100.50 shows the current volume of this metric. Aprea Therapeutics is pursuing a global expansion of its DDR inhibitor portfolio to capture the oncotherapy market by developing tumor suppressor restoration drugs with high margin potential.

aprea.com (APRE) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

Aprea (APRE) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:aprea.com (APRE)
Barang unggulan Aprea Therapeutics Inc.

The business resilience of Aprea Therapeutics (APRE) depends on the successful market launch of eprenostat for oncohematology therapy. By analyzing this quarterly revenue chart, an investor tracks the percentage change in current quarter revenues compared to the same period last year, which allows for the identification of early signs of stagnation or accelerated drug commercialization to determine the fair market value of the assets.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Dinamika pendapatan kuartal marang kuartal|KZIA: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Silexion Therapeutics|NuCana plc (NCNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Chimerix, Inc|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)